![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.395 | -8.31% | 4.36 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 143,012 | 08:44:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/5/2020 09:27 | Sorry but sadly this is not looking good imo ! | ![]() paradise city | |
27/5/2020 09:26 | It doesn't get unblinded until all patients have completed the 28 days post 1st dose, so no one will know. My feeling is that the hospital results will provide some useful data showing some efficiency but it's when you treat earlier (ie home trial) that will show significant results. It's a waiting game. Just hope they get their skates on an really drive fast recruitment. Given the level care hopefully that won't be too much of an issue. | ![]() waterloo01 | |
27/5/2020 09:19 | Lower Low & Lower High | darkhearse | |
27/5/2020 09:14 | What is happening here. Never thought we would see sub 50p | ![]() imjustdandy | |
27/5/2020 09:14 | Flaky holders moving on to to try their luck elsewhere, longer wait seems to have spooked a few. | ![]() wardy333 | |
27/5/2020 09:12 | The interview with Proactive wasn’t upbeat enough, at least from my point of view, and we’ll have to wait till August for some real results. Unless something happens in the meantime, I guess it’ll drift. I’ll pick up some more if it continues drifting D | ![]() dennisbergkamp | |
27/5/2020 09:10 | Must have hit a few stop losses - now bounce? | ![]() ali g2 | |
27/5/2020 09:08 | Given there is unlikely to be need for 1month it may drift. Perhaps buy some more if it's lower | ![]() money4me | |
27/5/2020 09:06 | How is spike to 58 yesterday followed by this. Market is bent as. This has been played for a long time now really. | ![]() dealer55 | |
27/5/2020 09:05 | Good job my AV is mid 30! Check your screen in a month simples | nick9013 | |
27/5/2020 09:04 | They are offering 46.6p for quantity so will have to up the bid | ![]() vitec | |
27/5/2020 08:56 | Can we assume, in the absence of any further TR1s that Lansdowne are no longer sellers? | ![]() wetdream | |
27/5/2020 08:53 | Nearly there then. | ![]() eeza | |
27/5/2020 08:52 | Yes long and strong, if it goes down I'll fill up simples! | ![]() bobaxe1 | |
27/5/2020 08:47 | Well that's 50 gone - not sure where next support lies. | ![]() toffeeman | |
27/5/2020 08:47 | For the so called "longer" term investors it absolutely makes no sense to watch the share price everyday and if red getting nervous. Nervousity is a mad ground for making wrong decisions (sell button...). Fundamentally nothing has changed. It is known when we get the results. Until then I do not see any reasons why to follow the herd. With the smallest glimpse of positivity out of Synairgens trial development the entire herd will quickly come back and bring more with them. So don´t worry. Typical market behaviour when you have to purely stick to your DD and not let shacking your standpoint! | oilhunter2020 | |
27/5/2020 08:45 | Seems like the market just want a vaccine and not a stop gap ! | ![]() paradise city | |
27/5/2020 08:37 | Don’t think it’s a sinking ship, it’s just passengers have the opportunity to go on a booze cruise for a couple of months or wait around and see the value of their tickets depreciate, in the main due the main investors in the boat selling. Keeping some back to buy more but will be through gritted teeth | ![]() talk2dubya | |
27/5/2020 08:30 | Vitec .... exactly. The ships never been in better order ! | ![]() peachie 74 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions